Lief Therapeutics
PrivateLast Round
Grant
Mar 2, 2026
Total Funding Raised
$4.12M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Lief Therapeutics operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Grant round in March 2026.
Lief Therapeutics is a digital health company that develops wearable biosensing patches and mobile applications to provide real-time heart rate variability (HRV) biofeedback for mental health management.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Medical Devices, Health IoT
Business Model
B2C
Customer Profile
Hardware + Subscription, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lief Therapeutics Comparables
Compare Lief Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| The TouchPoint Solution | 78% | |
| Apollo Neuro | 78% | |
| Hoolest Inc. | 78% |
For institutional investors. Book with your work email.
Lief Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 2, 2026 | ||||
| Accelerator | Jul 25, 2019 | ||||
| Crowdfunding | Jan 10, 2017 | ||||
| Crowdfunding | Nov 29, 2016 | ||||
| Seed | Aug 1, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lief Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartX | Seed |
| Nashville Entrepreneur Center | Accelerator |
| Ayuh Ventures | Early Funding, Seed |
| ARPA-H | Grant |
| HAX | Crowdfunding, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
$4M grant received from ARPA-H.
- Jan 10, 2017
Raised $406K in a crowdfunding round.
For institutional investors. Book with your work email.
Lief Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lief Therapeutics's valuation, stock price, and market status.
Is Lief Therapeutics a public or private company?
Lief Therapeutics is a private company.
What is the current stock price of Lief Therapeutics?
Lief Therapeutics is a private company, so its shares have no public market price. Caplight tracks Lief Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lief Therapeutics worth (valuation)?
Valuation information for Lief Therapeutics is not publicly available.
Can I buy Lief Therapeutics stock?
Lief Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lief Therapeutics's last funding round?
Lief Therapeutics's most recent funding round was Grant on March 2, 2026.
Who are the main investors in Lief Therapeutics?
Key investors in Lief Therapeutics include StartX, Nashville Entrepreneur Center, Ayuh Ventures, ARPA-H, HAX.
Will Lief Therapeutics IPO soon?
No public IPO plans have been announced for Lief Therapeutics.
How can I track Lief Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Lief Therapeutics's shares on secondary markets.